10x Genomics (TXG) News Today $9.34 +0.48 (+5.42%) Closing price 05/29/2025 04:00 PM EasternExtended Trading$9.20 -0.14 (-1.50%) As of 05/29/2025 07:55 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock TXG Latest News All Sources Trusted Sources MarketBeat Benzinga Bloomberg GlobeNewswire GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent May 2025 April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 Time Period Insider Selling: 10x Genomics, Inc. (NASDAQ:TXG) CFO Sells 4,044 Shares of Stock10x Genomics, Inc. (NASDAQ:TXG - Get Free Report) CFO Adam Taich sold 4,044 shares of the stock in a transaction on Thursday, May 22nd. The stock was sold at an average price of $8.30, for a total value of $33,565.20. Following the completion of the sale, the chief financial officer now owns 331,588 shares in the company, valued at approximately $2,752,180.40. The trade was a 1.20% decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this hyperlink.May 29 at 8:08 PM | marketbeat.comInsider Selling: 10x Genomics, Inc. (NASDAQ:TXG) Insider Sells 7,485 Shares of Stock10x Genomics, Inc. (NASDAQ:TXG - Get Free Report) insider Benjamin J. Hindson sold 7,485 shares of 10x Genomics stock in a transaction dated Thursday, May 22nd. The shares were sold at an average price of $8.30, for a total value of $62,125.50. Following the completion of the transaction, the insider now owns 448,374 shares of the company's stock, valued at $3,721,504.20. The trade was a 1.64% decrease in their position. The sale was disclosed in a document filed with the SEC, which is accessible through this link.May 29 at 8:07 PM | marketbeat.comInsider Selling: 10x Genomics, Inc. (NASDAQ:TXG) CEO Sells 9,343 Shares of Stock10x Genomics, Inc. (NASDAQ:TXG - Get Free Report) CEO Serge Saxonov sold 9,343 shares of the business's stock in a transaction dated Thursday, May 22nd. The shares were sold at an average price of $8.30, for a total transaction of $77,546.90. Following the completion of the sale, the chief executive officer now directly owns 1,083,625 shares of the company's stock, valued at approximately $8,994,087.50. This trade represents a 0.85% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link.May 29 at 8:07 PM | marketbeat.comAdam Taich Sells 4,044 Shares of 10x Genomics, Inc. (NASDAQ:TXG) StockMay 28 at 5:30 AM | insidertrades.comUBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC Purchases 193,588 Shares of 10x Genomics, Inc. (NASDAQ:TXG)UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC grew its position in shares of 10x Genomics, Inc. (NASDAQ:TXG - Free Report) by 10.1% during the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 2,116,573 sharMay 28 at 4:48 AM | marketbeat.com10x Genomics' (TXG) "Sell (E+)" Rating Reiterated at Weiss RatingsWeiss Ratings reaffirmed a "sell (e+)" rating on shares of 10x Genomics in a research note on Saturday.May 28 at 2:34 AM | marketbeat.comWeiss Ratings Reiterates "Sell (E+)" Rating for 10x Genomics (NASDAQ:TXG)May 27 at 4:35 AM | americanbankingnews.com10x Genomics (NASDAQ:TXG) Earns Sell (E+) Rating from Weiss RatingsMay 27 at 3:53 AM | americanbankingnews.comSquarepoint Ops LLC Sells 121,729 Shares of 10x Genomics, Inc. (NASDAQ:TXG)Squarepoint Ops LLC lessened its position in 10x Genomics, Inc. (NASDAQ:TXG - Free Report) by 17.1% during the 4th quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 590,510 shares of the company's stock after selling 121,729 shares duringMay 26, 2025 | marketbeat.com10x Genomics, Inc. (NASDAQ:TXG) Shares Purchased by Man Group plcMan Group plc increased its stake in shares of 10x Genomics, Inc. (NASDAQ:TXG - Free Report) by 77.6% in the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 126,666 shares of the company's stock after purchasing aMay 26, 2025 | marketbeat.com10x Genomics, Inc. (NASDAQ:TXG) Shares Sold by Bank of America Corp DEBank of America Corp DE lowered its position in shares of 10x Genomics, Inc. (NASDAQ:TXG - Free Report) by 30.0% in the fourth quarter, according to the company in its most recent filing with the SEC. The firm owned 654,999 shares of the company's stock after selling 281,259 shares during the quartMay 26, 2025 | marketbeat.comVoloridge Investment Management LLC Boosts Holdings in 10x Genomics, Inc. (NASDAQ:TXG)Voloridge Investment Management LLC lifted its stake in 10x Genomics, Inc. (NASDAQ:TXG - Free Report) by 12.1% in the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The firm owned 1,585,965 shares of the company's stock after purchasMay 25, 2025 | marketbeat.comTwo Sigma Investments LP Has $18.95 Million Stock Position in 10x Genomics, Inc. (NASDAQ:TXG)Two Sigma Investments LP increased its stake in shares of 10x Genomics, Inc. (NASDAQ:TXG - Free Report) by 291.2% during the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm owned 1,319,487 shares of the company's stock after acquiring anMay 25, 2025 | marketbeat.com10x Genomics (NASDAQ:TXG) Upgraded by Wall Street Zen to Buy RatingWall Street Zen raised 10x Genomics from a "hold" rating to a "buy" rating in a report on Thursday.May 24, 2025 | marketbeat.com10x Genomics, Inc. (NASDAQ:TXG) Shares Acquired by Two Sigma Advisers LPTwo Sigma Advisers LP increased its position in shares of 10x Genomics, Inc. (NASDAQ:TXG - Free Report) by 240.6% during the 4th quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 1,236,200 shares of the company's stock after buying an addMay 24, 2025 | marketbeat.comMIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. Has $2.29 Million Stake in 10x Genomics, Inc. (NASDAQ:TXG)MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. grew its stake in 10x Genomics, Inc. (NASDAQ:TXG - Free Report) by 37.0% during the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor owned 159,165 shares of the company'sMay 24, 2025 | marketbeat.comWhy 10x Genomics Stock Was Sliding This WeekMay 23, 2025 | msn.comQuantinno Capital Management LP Has $2.15 Million Position in 10x Genomics, Inc. (NASDAQ:TXG)Quantinno Capital Management LP trimmed its stake in 10x Genomics, Inc. (NASDAQ:TXG - Free Report) by 36.2% in the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 149,833 shares of the company's stock after selling 85,193 sharMay 23, 2025 | marketbeat.com10x Genomics, Inc. (NASDAQ:TXG) Shares Sold by Northern Trust CorpNorthern Trust Corp trimmed its holdings in 10x Genomics, Inc. (NASDAQ:TXG - Free Report) by 5.4% during the fourth quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The institutional investor owned 561,666 shares of the company's stock afteMay 21, 2025 | marketbeat.comMorgan Stanley Lowers 10x Genomics (NASDAQ:TXG) Price Target to $18.00May 21, 2025 | americanbankingnews.com10x Genomics (NASDAQ:TXG) Shares Down 4.8% on Analyst DowngradeMay 21, 2025 | americanbankingnews.comJacobs Levy Equity Management Inc. Buys Shares of 31,367 10x Genomics, Inc. (NASDAQ:TXG)Jacobs Levy Equity Management Inc. bought a new stake in 10x Genomics, Inc. (NASDAQ:TXG - Free Report) during the 4th quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor bought 31,367 shares of the company'sMay 20, 2025 | marketbeat.comJefferies Financial Group Inc. Has $446,000 Stock Holdings in 10x Genomics, Inc. (NASDAQ:TXG)Jefferies Financial Group Inc. trimmed its position in 10x Genomics, Inc. (NASDAQ:TXG - Free Report) by 90.1% during the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 31,048 shares of the company's stock after selling 284,0May 19, 2025 | marketbeat.comNumerai GP LLC Has $2.27 Million Stake in 10x Genomics, Inc. (NASDAQ:TXG)Numerai GP LLC raised its stake in shares of 10x Genomics, Inc. (NASDAQ:TXG - Free Report) by 66.8% in the 4th quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The fund owned 157,792 shares of the company's stock after purchasing an additionMay 16, 2025 | marketbeat.comCresset Asset Management LLC Cuts Position in 10x Genomics, Inc. (NASDAQ:TXG)Cresset Asset Management LLC lessened its holdings in 10x Genomics, Inc. (NASDAQ:TXG - Free Report) by 69.6% during the fourth quarter, according to the company in its most recent disclosure with the SEC. The firm owned 41,619 shares of the company's stock after selling 95,302 shares during the quaMay 16, 2025 | marketbeat.comMeridiem Capital Partners LP Invests $4.92 Million in 10x Genomics, Inc. (NASDAQ:TXG)Meridiem Capital Partners LP bought a new stake in shares of 10x Genomics, Inc. (NASDAQ:TXG - Free Report) during the 4th quarter, according to its most recent filing with the Securities and Exchange Commission. The firm bought 342,870 shares of the company's stock, valued at approximately $4,924,0May 15, 2025 | marketbeat.comD. E. Shaw & Co. Inc. Invests $17.50 Million in 10x Genomics, Inc. (NASDAQ:TXG)D. E. Shaw & Co. Inc. purchased a new stake in shares of 10x Genomics, Inc. (NASDAQ:TXG - Free Report) in the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm purchased 1,218,598 shares of the company's stock, valued at approximately $17,May 15, 2025 | marketbeat.comBalyasny Asset Management L.P. Buys 95,820 Shares of 10x Genomics, Inc. (NASDAQ:TXG)Balyasny Asset Management L.P. increased its stake in 10x Genomics, Inc. (NASDAQ:TXG - Free Report) by 216.5% during the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The fund owned 140,075 shares of the company's stock after purchaMay 15, 2025 | marketbeat.comThe Manufacturers Life Insurance Company Trims Stake in 10x Genomics, Inc. (NASDAQ:TXG)The Manufacturers Life Insurance Company reduced its position in shares of 10x Genomics, Inc. (NASDAQ:TXG - Free Report) by 32.6% during the 4th quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The firm owned 88,820 shares of the company's stock afterMay 15, 2025 | marketbeat.com10x Genomics Announces Patent Litigation Settlement Agreement with BrukerMay 14, 2025 | prnewswire.comThe Goldman Sachs Group Lowers 10x Genomics (NASDAQ:TXG) Price Target to $6.50The Goldman Sachs Group dropped their price target on 10x Genomics from $7.50 to $6.50 and set a "sell" rating on the stock in a research note on Monday.May 14, 2025 | marketbeat.com10x Genomics (NASDAQ:TXG) Given New $15.00 Price Target at Canaccord Genuity GroupCanaccord Genuity Group dropped their price target on shares of 10x Genomics from $18.00 to $15.00 and set a "buy" rating on the stock in a research note on Monday.May 14, 2025 | marketbeat.com189,221 Shares in 10x Genomics, Inc. (NASDAQ:TXG) Bought by Invenomic Capital Management LPInvenomic Capital Management LP purchased a new position in shares of 10x Genomics, Inc. (NASDAQ:TXG - Free Report) during the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The fund purchased 189,221 shares of the company's stock, vMay 14, 2025 | marketbeat.comBNP Paribas Financial Markets Purchases Shares of 632,531 10x Genomics, Inc. (NASDAQ:TXG)BNP Paribas Financial Markets purchased a new stake in shares of 10x Genomics, Inc. (NASDAQ:TXG - Free Report) during the 4th quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The fund purchased 632,531 shares of the company's stock, valuMay 14, 2025 | marketbeat.comJane Street Group LLC Purchases 117,449 Shares of 10x Genomics, Inc. (NASDAQ:TXG)Jane Street Group LLC boosted its position in 10x Genomics, Inc. (NASDAQ:TXG - Free Report) by 48.4% during the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 360,257 shares of the company's stock after acquiring an additionMay 13, 2025 | marketbeat.comCubist Systematic Strategies LLC Raises Position in 10x Genomics, Inc. (NASDAQ:TXG)Cubist Systematic Strategies LLC increased its position in shares of 10x Genomics, Inc. (NASDAQ:TXG - Free Report) by 49.4% in the 4th quarter, according to its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 334,632 shares of the company's stMay 12, 2025 | marketbeat.com30,005 Shares in 10x Genomics, Inc. (NASDAQ:TXG) Purchased by Raymond James Financial Inc.Raymond James Financial Inc. acquired a new stake in shares of 10x Genomics, Inc. (NASDAQ:TXG - Free Report) in the fourth quarter, according to the company in its most recent filing with the SEC. The firm acquired 30,005 shares of the company's stock, valued at approximately $431,000. Other largeMay 12, 2025 | marketbeat.com10x Genomics (NASDAQ:TXG) Receives Sell (E+) Rating from Weiss RatingsWeiss Ratings restated a "sell (e+)" rating on shares of 10x Genomics in a research report on Saturday.May 12, 2025 | marketbeat.com10x Genomics, Inc. (NASDAQ:TXG) Just Reported Earnings, And Analysts Cut Their Target PriceMay 11, 2025 | uk.finance.yahoo.comAQR Capital Management LLC Decreases Position in 10x Genomics, Inc. (NASDAQ:TXG)AQR Capital Management LLC decreased its position in shares of 10x Genomics, Inc. (NASDAQ:TXG - Free Report) by 29.1% during the fourth quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The fund owned 517,202 shares of the company's stockMay 10, 2025 | marketbeat.com10x Genomics (NASDAQ:TXG) shareholders have endured a 90% loss from investing in the stock five years agoMay 9, 2025 | finance.yahoo.com10x Genomics, Inc.: 10x Genomics Reports First Quarter 2025 Financial ResultsMay 9, 2025 | finanznachrichten.de10x Genomics’s (NASDAQ:TXG) Q1: Strong Sales But Quarterly Revenue Guidance Significantly Misses ExpectationsMay 9, 2025 | msn.com10x Genomics, Inc. (TXG) Q1 2025 Earnings Call TranscriptMay 8, 2025 | seekingalpha.com10x Genomics Reports First Quarter 2025 Financial ResultsMay 8, 2025 | prnewswire.comSchonfeld Strategic Advisors LLC Raises Holdings in 10x Genomics, Inc. (NASDAQ:TXG)Schonfeld Strategic Advisors LLC increased its position in shares of 10x Genomics, Inc. (NASDAQ:TXG - Free Report) by 140.4% during the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The firm owned 151,693 shares of the company's stoMay 8, 2025 | marketbeat.com10x Genomics Q1 2025 Earnings PreviewMay 7, 2025 | msn.com10x Genomics Q1 2025 Earnings PreviewMay 7, 2025 | msn.com10x Genomics (TXG) Reports Q1: Everything You Need To Know Ahead Of EarningsMay 7, 2025 | finance.yahoo.comAlgert Global LLC Has $9.49 Million Holdings in 10x Genomics, Inc. (NASDAQ:TXG)Algert Global LLC lifted its stake in shares of 10x Genomics, Inc. (NASDAQ:TXG - Free Report) by 78.1% during the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 660,620 shares of the company's stock after purchaMay 7, 2025 | marketbeat.com Get 10x Genomics News Delivered to You Automatically Sign up to receive the latest news and ratings for TXG and its competitors with MarketBeat's FREE daily newsletter. Email Address TXG Media Mentions By Week TXG Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. TXG News Sentiment▼0.860.87▲Average Medical News Sentiment TXG News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. TXG Articles This Week▼237▲TXG Articles Average Week Get 10x Genomics News Delivered to You Automatically Sign up to receive the latest news and ratings for TXG and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies Sensata Technologies News Camtek News Transcat News Allient News EyePoint Pharmaceuticals News Quantum-Si News Standard BioTools News Senseonics News Cytek Biosciences News Aehr Test Systems News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:TXG) was last updated on 5/30/2025 by MarketBeat.com Staff From Our PartnersBuffett’s Next Move Could Shock Wall StreetIn just a few weeks, a move decades in the making could be revealed — and when it is, it could ignite the next...Golden Portfolio | SponsoredElon Musk’s Frightening Warning Forces Trump’s HandElon Musk has avoided two major financial crises before. He pulled Tesla and SpaceX back from the brink of col...American Hartford Gold | SponsoredMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | SponsoredUrgent: Make this trade before you hit your pillow tonight… Most people waste 8 hours every night… And 227,916 hours in their lifetime… Dreaming about the life they...Timothy Sykes | SponsoredNow I look stupid. Real stupid... I thought what happened 25 years ago was a once- in-a-lifetime event… but how wrong I was. Because here we...Porter & Company | SponsoredAI Meltdown Imminent: Dump These Stocks Now!If you have any money in the markets, especially in AI stocks… Please click here to see Elon Musk’s new inv...Paradigm Press | SponsoredThis Signal Only Flashes Once Every 4 Years – And It Just TriggeredThis same signal has appeared twice before in the past 8 years — both times, it kicked off major moves in cryp...Crypto Swap Profits | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding 10x Genomics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share 10x Genomics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy TXG Stock Free TXG Stock Alerts